MENU

NEWSROOM

Title

  1. FUSCC signed a sister institution agreement with N.N. Blokhin NMRCO
  2. Fudan University Shanghai Cancer Center CUP001 was Presented at ESMO 2023 Professor Luo Zhiguo: The World's First Phase III Clinical Study in Patients with Cancer of Unknown Primary Met its Primary Endpoint
  3. Precise medicine, digital tech boost breast cancer treatment
  4. The 11th FUSCC-CRIKU Joint Symposium on Tumor Biology was convened at Kanazawa
  5. Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study
  6. Shanghai center tests nuclear medicine prostate cancer treatment
  7. Innovative scale developed to guide locally advanced thyroid cancer treatment
  8. Robotic surgery innovation center enhances prostate cancer treatment
  9. China-developed radiation equipment receives international recognition
  10. First PRRT clinical trial launched in Shanghai